​​Cell and Peptide-based Therapy for Ph+ Leukaemia

Principal Investigator: Dr Afsar Mian, Assistant Professor

Co-PI: Dr Hammad Hassan, Assistant Professor​

Dr Afsar Mian and Dr Hammad Hassan are working on developing novel drugs and treatment approaches for treatment-resistant Leukaemia, a type of blood cancer. Their current focus is on designing a cell and peptide-based method for treating Philadelphia-positive Leukaemia. It is expected that, unlike the existing treatment methods, the new therapy wouldn't require repetitive administration, hence, reducing treatment cost and drug manipulation risks.​​

The specific objectives of this research are:

  • ​Developing the treatment-resistant Leukaemia model

  • Investigating the mechanisms of drug resistance which results in disease relapse

  • Developi​ng novel compounds for targetted treatment​​​

​Principal Investigator​​​​​​​​​​​

Dr Afsar Mian​

Assi​stant Professor ​

hpicon_voice_calling1.png +92 21 3486 5542​​

2  Email Logo.png ​ afsar.mian@aku.edu​​

​Relat​ed News​ 

AKU wins Rs14.5m HEC grant ​to develop stem-cell treatments

This grant will support researchers at AKU-CRM to explore the potential of stem cell treatment for a​ common form of leukaemia.